These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18829437)

  • 1. Single-particle kinetics of influenza virus membrane fusion.
    Floyd DL; Ragains JR; Skehel JJ; Harrison SC; van Oijen AM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15382-7. PubMed ID: 18829437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for measurement of viral fusion kinetics at the single particle level.
    Floyd DL; Harrison SC; van Oijen AM
    J Vis Exp; 2009 Sep; (31):. PubMed ID: 19736545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers.
    Matos PM; Marin M; Ahn B; Lam W; Santos NC; Melikyan GB
    J Biol Chem; 2013 May; 288(18):12416-25. PubMed ID: 23493401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Hemifusion Phenotype Depends on Membrane Context: Differences in Cell-Cell and Virus-Cell Fusion.
    Zawada KE; Okamoto K; Kasson PM
    J Mol Biol; 2018 Mar; 430(5):594-601. PubMed ID: 29355500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-virus content-mixing assay reveals cholesterol-enhanced influenza membrane fusion efficiency.
    Liu KN; Boxer SG
    Biophys J; 2021 Nov; 120(21):4832-4841. PubMed ID: 34536389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates.
    Ivanovic T; Choi JL; Whelan SP; van Oijen AM; Harrison SC
    Elife; 2013 Feb; 2():e00333. PubMed ID: 23550179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion.
    Klein S; Golani G; Lolicato F; Lahr C; Beyer D; Herrmann A; Wachsmuth-Melm M; Reddmann N; Brecht R; Hosseinzadeh M; Kolovou A; Makroczyova J; Peterl S; Schorb M; Schwab Y; Brügger B; Nickel W; Schwarz US; Chlanda P
    Cell Host Microbe; 2023 Apr; 31(4):616-633.e20. PubMed ID: 37003257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
    Desai TM; Marin M; Chin CR; Savidis G; Brass AL; Melikyan GB
    PLoS Pathog; 2014 Apr; 10(4):e1004048. PubMed ID: 24699674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
    Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluating herpes simplex virus hemifusion.
    Jackson JO; Longnecker R
    J Virol; 2010 Nov; 84(22):11814-21. PubMed ID: 20844038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling Viral Membrane Fusion from Receptor Binding Using Synthetic DNA-Lipid Conjugates.
    Rawle RJ; Boxer SG; Kasson PM
    Biophys J; 2016 Jul; 111(1):123-31. PubMed ID: 27410740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of lipid-protein rearrangements during viral infection.
    Chizmadzhev YA
    Bioelectrochemistry; 2004 Jun; 63(1-2):129-36. PubMed ID: 15110263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.
    Joo KI; Tai A; Lee CL; Wong C; Wang P
    Microsc Res Tech; 2010 Sep; 73(9):886-900. PubMed ID: 20232362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Influenza Virus Envelope's Fusogenicity by Viral Fusion Inhibitors.
    Rowse M; Qiu S; Tsao J; Yamauchi Y; Wang G; Luo M
    ACS Infect Dis; 2016 Jan; 2(1):47-53. PubMed ID: 27622947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Developments in Single-Virus Fusion Assay.
    Haldar S
    J Membr Biol; 2022 Dec; 255(6):747-755. PubMed ID: 36173449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    Chernomordik LV; Frolov VA; Leikina E; Bronk P; Zimmerberg J
    J Cell Biol; 1998 Mar; 140(6):1369-82. PubMed ID: 9508770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization and Sequencing of Membrane Remodeling Leading to Influenza Virus Fusion.
    Gui L; Ebner JL; Mileant A; Williams JA; Lee KK
    J Virol; 2016 Aug; 90(15):6948-6962. PubMed ID: 27226364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Architecture of a nascent viral fusion pore.
    Lee KK
    EMBO J; 2010 Apr; 29(7):1299-311. PubMed ID: 20168302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemagglutinin fusion peptide mutants in model membranes: structural properties, membrane physical properties, and PEG-mediated fusion.
    Haque ME; Chakraborty H; Koklic T; Komatsu H; Axelsen PH; Lentz BR
    Biophys J; 2011 Sep; 101(5):1095-104. PubMed ID: 21889446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.
    Clague MJ; Schoch C; Blumenthal R
    J Virol; 1991 May; 65(5):2402-7. PubMed ID: 1850019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.